Fintech PR

Suplari to Build Custom AI-Powered Insights Applications for Enterprises

Published

5 years ago

April 8, 2019

Newsfile

Reading Time: 3 minutes

Suplari, the AI-powered intelligent spend management system for enterprise procurement and finance, today unveiled a new program to build Custom Insights Applications for its customers. Insights are always-on, intelligent applications in Suplari. The Insights Applications automatically and persistently monitor enterprise data, and proactively detect opportunities to optimize spend, risk and compliance. With this new Custom Insights program, Suplari can rapidly develop Insights Applications, specific to each business, to tackle their hardest strategic problems, operational optimization needs and data blind spots. The announcement happens during ISM 2019 Spark Event, hosted by the Institute for Supply Management in Houston, where team Suplari will be presenting its system and new Insights.

Insights Applications are Always-On Opportunity Detectors, to Optimize Productivity, Spend, Risk and Compliance – the proactive, efficient and accountable way.

Finance and procurement are under constant pressure to optimize spend, risk and compliance – but struggle to get timely and actionable insights into spend and supplier activity. Basic and static reporting are no longer sufficient. Suplari makes sense of customers spend data sources and supplier activity. The system runs Insights Applications using algorithms that enable persistent monitoring, timely alerting and proactive resolution of optimization opportunities.

Highlighted examples of Suplari’s built-in Insights Applications include the ones detecting optimization opportunities for: outlier and suspicious transactions, employee subscriptions and purchasing activity, early contract renewal and negotiation, demand aggregation, purchasing process violations, and much more.

This more automated, proactive, accountable approach also saves customers the time wasted on fixing data and crunching reports. Teams can then become more agile, and focus on what matters most – decisions, relationships and value creation.

Custom Insights Drive Intelligence from Finance, Operations and Procurement Data

“Enterprises are operating in a time of increasing volatility, disruption and opportunity,” said Nikesh Parekh, Co-founder and CEO at Suplari. Every enterprise is looking for solutions to increase back-office productivity, drive intelligence from their data, and proactively drive execution. Yet, the solutions need to be unique to each enterprise’s operating model and strategic challenge. Suplari frees the data from traditional systems and drive proactive, customized answers to company-specific challenges.”

To build the Custom Insights, Suplari starts with connecting data sources across disparate systems. Then runs algorithms that automatically monitor data and detect optimization opportunities. The applications also render easy to use data explorers, rich analytics, alerting and tracking of opportunities. All those capabilities come together to help close the full loop from identifying and investigating opportunities all the way to resolving them and capturing the actual outcomes.

Enterprise finance and procurement teams engage Suplari and apply Custom Insights to solve core challenges they face:

Blind spots in spend data and operations management
Data sets that need to be connected and monitored
Unique KPI or cost allocation to be better tracked
Uncovering hidden costs, risks or fraud
Strategic business initiatives, missing relevant metrics

“The use cases are broad and revolutionary,” added Parekh. For example: a retailer powerhouse needed to monitor preferred and rogue spend in fulfillment centers to improve sourcing; an electronics manufacturer connecting part inventory management to revenue forecast; an insurance company needed insights into driving greater adoption and compliance to their PO process. Other customers wanted visibility into rogue behaviors, risk factors, budget tracking and departmental expenses. The possibilities are limitless.”

Making it All Possible with Insights Generator: Our Integrated Development & Data Science Environment

Suplari is constantly expanding its catalog of Insights Applications. The ability to rapidly develop both built-in as well as Custom Insights relies on Suplari’s proprietary Insights Generator technology. The Insights Generator is Suplari’s proprietary integrated development and data science environment. It leverages cloud infrastructure, Kubernetes clusters, machine learning and pervasive data science technologies such as Python, Jupiter and Pandas. The Insights Generator give data scientists control and versatility for the rapid development of intelligent applications, helping solve any enterprises mission-critical challenge.

Suplari’s Insights Generator was architected and designed by Suplari’s CTO Jeff Gerber, former CTO of iConclude / HP Business Service Automation and former Chief Architect of Apptio. “We founded Suplari to build intelligent applications for the enterprise,” said Gerber. “We are experiencing a revolution in AI advancement. In the consumer space, we now have intelligent assistants that can do your shopping, screen your calls, find the music you like or even recognize friends and family in your photo collection. Bringing this type of innovation to the enterprise, Suplari helps customers identify business optimization opportunities – in a way that was not possible to find using traditional techniques or basic analytics. We are applying AI to the messy, disconnected and siloed enterprise dataset and enabling a new order of intelligence, automation and agility for our customers.”

Equipped with these AI-powered Insights Applications, pre-packaged or custom, enterprise finance and procurement teams can build a rich opportunity pipeline, with a variety of contributing tactics and levers, and an accelerated pace to hit cost savings, risk and compliance optimization goals. They can turn spend management into an enterprise-wide, accountable and ongoing practice, rather than reactive, one-off initiatives.

To learn more about Suplari’s Intelligent Spend Management System and the new Custom Insights program, visit www.suplari.com.

SOURCE Suplari

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

2 weeks ago

April 5, 2024

CISION (PR Newswire)

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf	Invitation to presentation of EQT AB’s Q1 Announcement 2024
https://news.cision.com/eqt/i/eqt-ab-group,c3285895	EQT AB Group

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

2 weeks ago

April 5, 2024

CISION (PR Newswire)

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs

Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

2 weeks ago

April 5, 2024

CISION (PR Newswire)

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html